We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

56 hedge funds and large institutions have $215M invested in Five Prime Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 25 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 4

257% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 7

68% more capital invested

Capital invested by funds: $128M → $215M (+$87.2M)

33% more funds holding

Funds holding: 42 → 56 (+14)

Holders
56
Holders Change
+14
Holders Change %
+33.33%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
25
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$18.3M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$15.9M
3
BI
BVF Inc
California
+$11.5M
4
EAM
Eventide Asset Management
Massachusetts
+$8.71M
5
Millennium Management
Millennium Management
New York
+$5.22M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$13.3M
2
WT
Wellcome Trust
United Kingdom
-$2.64M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.14M
4
Deutsche Bank
Deutsche Bank
Germany
-$760K
5
PAM
Panagora Asset Management
Massachusetts
-$428K
Name Holding Trade Value Shares
Change 		Change in
Stake
GPCM
26
Granite Point Capital Management
Massachusetts
$1.13M +$638K +37,600 +188%
SAM
27
Senzar Asset Management
New York
$958K +$827K +48,700 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$893K +$270K +15,899 +54%
TAM
29
Tocqueville Asset Management
New York
$787K +$680K +40,025 New
Allianz Asset Management
30
Allianz Asset Management
Germany
$768K -$355K -20,883 -35%
SAM
31
Sectoral Asset Management
Quebec, Canada
$636K +$550K +32,372 New
PAM
32
Panagora Asset Management
Massachusetts
$567K -$428K -25,218 -47%
TRSOTSOK
33
Teachers Retirement System of the State of Kentucky
Kentucky
$527K +$455K +26,800 New
NFA
34
Nationwide Fund Advisors
Ohio
$510K +$370K +21,763 +518%
BCM
35
Bridgeway Capital Management
Texas
$472K +$408K +24,000 New
SC
36
Sophrosyne Capital
New York
$438K +$379K +22,300 New
TCIM
37
TIAA CREF Investment Management
New York
$400K +$88.3K +5,200 +34%
BBA
38
Baker Bros. Advisors
New York
$390K – – –
BIM
39
BlackRock Investment Management
Delaware
$381K +$112K +6,618 +52%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$378K +$133K +7,825 +69%
TA
41
Teachers Advisors
New York
$288K +$155K +9,110 +164%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$242K +$35.7K +2,100 +21%
TC
43
TFS Capital
Pennsylvania
$242K +$209K +12,307 New
Citigroup
44
Citigroup
New York
$210K +$135K +7,950 +292%
Deutsche Bank
45
Deutsche Bank
Germany
$152K -$760K -44,749 -85%
Morgan Stanley
46
Morgan Stanley
New York
$106K +$83.2K +4,901 +1,063%
AIG
47
American International Group
New York
$75.1K +$1.56K +92 +2%
BA
48
BlackRock Advisors
Delaware
$74K -$44.2K -2,605 -41%
Federated Hermes
49
Federated Hermes
Pennsylvania
$36K +$30.9K +1,818 New
U
50
UBS
Switzerland
$23K +$12.2K +717 +156%
1
2
3

FPRX Hedge Fund Activity: Q1 2014 in Review

56 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q1 2014, worth a combined $215M — up 68% from $128M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FPRX positions and 4 closed out — a net gain of 15 holders — while 25 added to existing stakes and 7 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $18.3M. The largest seller was HealthCor Management, cutting an estimated $13.3M.

  • 56 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q1 2014, up from 42 in Q4 2013.
  • Funds reported $215M of Five Prime Therapeutics, Inc. stock for Q1 2014, up 68% quarter-over-quarter.
  • 19 funds opened new Five Prime Therapeutics, Inc. positions in Q1 2014 and 4 closed out, a net change of +15 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q1 2014 was OrbiMed, an estimated $18.3M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q1 2014 was HealthCor Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2014.